Black Bird Biotech Inc. (OTCMKTS:BBBT) Stock Sees Selling Pressure: Down 25%

Black Bird Biotech Inc. (OTCMKTS:BBBT) was down 25% after offering a statement thanking veterans and their families.

Trading Data

On Thursday, BBBT stock fell 2% at $0.0172 with more than 5.77 million shares, compared to its average volume of 5.53 million shares. The stock has moved within a range of $0.0160 – 0.0180 after opening the trade at $0.0175.

Major News

The statement said that the Black Bird Biotech team would like to extend gratitude to all Great Veterans who have served the country and show every attribute that makes the US a great nation in human history. In addition, Black Bird Biotech said they honor those who have paid the ultimate sacrifice that the United States of America continues to be the Land for the Free. Also, the company thanked the generations of families that have persevered through adversity and never wavered in their support for their servicewomen and servicemen.

The MiteXstream biopesticide manufacturer updated its ongoing progress and current status after finalizing its Regulation A funding. The company has used part of the proceeds from the funding to repay around $700,000 of its convertible debt with around $1 million remaining for investment to drive MiteXstream sales. Therefore, investors should watch BBBT.

Technical Data

BBBT stock is trading below the 20-Day and 50-Day Moving averages of $0.0196 and $0.0215 respectively. Moreover, the stock is trading below 200-Day moving average of $0.0315. The stock is down 34% in the past 3-month.